Abstract:OBJECTIVE:To investigate the impact of primary hypertension on angiogenesis in the tissues of benign prostatic hyperplasia (BPH). METHODS:Immunohistochemistry was carried out to examine the expression of CD34, so as to calculate the microvassel density (MVD), and the expression of vascular endothelial growth factor (VEGF) in the tissues of prostatic gland, resected during operation, of 50 simple BPH patients, aged 68.3 (56 approximately 83), and 50 patients with BPH with hypertension, aged 69.0 (55 approximately 91) with a course of hypertension of 16.5 +/- 11.9 years (1 - 41 years). RESULTS:The MVD of the simple BPH group was 23.1 +/- 9.2, significantly lower than that of the BPH complicated with hypertension group (28.2 +/- 9.5, P < 0.01), especially the BPH complicated with hypertension group with a course >/= 15 years (31.3 +/- 8.5). The MVD of the BPH complicated with hypertension group with a course >/= 15 years was significantly higher than that of the BPH complicated with hypertension group with a course < 15 years (25.7 +/- 9.7, P < 0.05). The VEGF positive rate of the stroma of the simple BPH group was 46.0%, significantly lower than that of the BPH complicated with hypertension group (66.0%, P < 0.05), especially that of the BPH complicated with hypertension group with a course >/= 15 years (81.8%). The VEGF positive rate of the stroma of the BPH complicated with hypertension group with a course >/= 15 years was significantly higher than that of the BPH complicated with hypertension group with a course < 15 years (53.6%, P < 0.05). In the group of BPH with hypertension, MVD was positively correlated with the expression of VEGF in the stromal tissue (R = 0.11, P < 0.05). CONCLUSION:Hypertension may be closely related to the increased expression of VEGF in prostatic stroma. The increased expression of VEGF may induce angiogenesis and consequently lead to clinical progression of BPH in patients with hypertension.

Expression of Pigment Epithelium-Derived Factor and Vascular Endothelial Growth Factor in Benign Prostatic Hyperplasia

Pigment Epithelial-Derived Factor Expression in Endometriotic Lesions in a Rat Model of Endometriosis.

[Expression of Tyrosine Phosphatase Containing C-src Homology SH-2 in Benign Prostate Hyperplasia].

Vascular endothelial growth factor on function of endothelial progenitor cells from peripheral blood

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

The Endothelial Function Study of Benign Prostatic Hyperplasia

Decreased Expression of Pigment Epithelium-Derived Factor and Increased Microvascular Density in Ovarian Endometriotic Lesions in Women with Endometriosis.

Relationship between the Expression of Estrogen Receptor α and Basal Cell Dedifferentiation in Benign Prostatic Hyperplasia

The Expression of PEDF in Bladder Cancer and Its Clinical Significance

Cdna Microarray Analysis of Pigment Epithelium-Derived Factor-Regulated Gene Expression Profile in Prostate Carcinoma Cells.

Expression of Pigment Epithelium-Derived Factor and Tumor Necrosis Factor-Α is Correlated in Bladder Tumor and is Related to Tumor Angiogenesis.

Pigment epithelium-derived factor plays an inhibitory role in proliferation and migration of HaCaT cells

Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate

[Expression of Placental Growth Factor and Pigment Epithelium-Derived Factor in Non-Small Cell Lung Cancer and the Prognostic Significance Thereof].

Increased expressions of VEGF and VEGF-C in prostate cancer tissue are associated with tumor progression

Pigment Epithelium-Derived Factor Expression is Down-Regulated in Bladder Tumors and Correlates with Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9

Expression of Pigment Epithelium-Derived Factor in Human Cutaneous Appendages

The correlation of VEGF expression with MVD in renal pelvic carcinoma and its clinical significance

Correlation Between Molecular Biomarkers and Risk Factors for the Clinical Progression of Benign Prostatic Hyperplasia Using Tissue Micro Array Immuno Staining

[Impact of Hypertension on Angiogenesis in the Tissues of Benign Prostatic Hyperplasia].

Regulation of CCN1 on angiogenesis in benign prostatic hyperplasia